The P0 Gene

Myelin Biology and Disorders

Volumn 1, Issue , 2004, Pages 523-545

  Kirschner, Daniel A ^a   Wrabetz, Lawrence ^b   Feltri, Maria Laura ^b  

^a BOSTON COLLEGE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903003705     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50073-5     Document Type: Chapter

References (160)

1. Akagi K., Sandig V., Vooijs M., Van der Valk M., Giovannini M., Strauss M., Berns A. Cremediated somatic site-specific recombination in mice. Nucleic Acids Res. 1997, 25:1766-1773.
2. Awatramani R., Shumas S., Kamholz J., Scherer S.S. TGFbeta1 modulates the phenotype of Schwann cells at the transcriptional level. Mol. Cell Neurosci. 2002, 19:307-319.
3. Barbu M. Molecular cloning of cDNAs that encode the chicken P0 protein: Evidence for early expression in avians. J. Neurosci. Res. 1990, 25:143-151.
4. Baron P., Shy M., Honda H., Sessa M., Kamholz J., Pleasure D. Developmental expression of Po mRNA and Po protein in the sciatic nerve and the spinal nerve roots of the rat. J. Neurocytol. 1994, 23:249-257.
5. Bermingham J.R., Scherer S.S., O'Connell S., Arroyo E., Kalla K.A., Powell F.L., Rosenfeld M.G. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 1996, 10:1751-1762.
6. Besancon R., Prost A.L., Konecny L., Latour P., Petiot P., Boutrand L., Kopp N., Mularoni A., Chamba G., Vandenberghe A. Alternative exon 3 splicing of the human major protein zero gene in white blood cells and peripheral nerve tissue. FEBS Lett. 1999, 457:339-342.
7. Bharucha V.A., Peden K.W., Tennekoon G.I. SV40 large T antigen with c-Jun down-regulates myelin P0 gene expression: A mechanism for papovaviral T antigen-mediated demyelination. Neuron 1994, 12:627-637.
8. Bhattacharyya A., Frank E., Ratner N., Brackenbury R. P0 is an early marker of the Schwann cell lineage in chicken. Neuron 1991, 7:831-844.
9. Bienfait H.M.E., Baas F., Gabreëls-Festen A.A.W.M., Koelman J.H.T.M., Langerhorst C.T., De Visser M. Two amino-acid substitutions in the myelin protien zero gene of a case of Charcot-Marie-Tooth disease associated with light-near dissociation. Neuromusc. Disord. 2002, 12:281-285.
10. msd and shi*jp phenotypes demonstrates dissimilar interactions of allelic mutations. Mol. Brain Res. 1987, 2:199-214.
11. Bizzozero O.A., Fridal K., Pastuszyn A. Identification of the palmitoylation site in rat myelin P0 glycoprotein. J. Neurochem. 1994, 62:1163-1171.
12. Blaurock A.E. Structure of the nerve myelin membrane: Proof of the low-resolution profile. J. Mol. Biol. 1971, 56:35-52.
13. Blaurock A.E. X-ray and neutron diffraction by membranes: How great is the potential for defining the moleuclear interactions?. Progress in Protein-Lipid Interactions 1986, Vol. 2:1. Elsevier. A. Watts, J.J.H.H.M. DePont (Eds.).
14. Bone L.J., Balice-Gordon R.J., Abel A., Messing A., Fischbeck K., Scherer S.S. Transgenic mice expressing a connexin 32 mutation develop demyelinating peripheral neuropathy. Soc. Neurosci. Abstr. 1997, 23:586.
15. Boulassel M.R., Guerit J.M., Denison S., de Tourtchaninoff M., Wenderickx L., Botterman N., Deggouj N., Gersdorff M., Tomasi J.P. No evidence of auditory dysfunction in guinea pigs immunized with myelin P0 protein. Hearing Res. 2001, 152:10-16.
16. Britsch S., Goerich D.E., Riethmacher D., Peirano R.I., Rossner M., Nave K.A., Birchmeier C., Wegner M. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001, 15:66-78.
17. Brösamle C., Halpern M.E. Characterization of myelination in the developing zebrafish. Glia 2002, 39:47-57.
18. Brown A.M., Lemke G. Multiple regulatory elements control transcription of the peripheral myelin protein zero gene. J. Biol. Chem. 1997, 272:28939-28947.
19. Brunden K.R., Poduslo J.F. A phorbol ester-sensitive kinase catalyzes the phosphorylation of P0 glycoprotein in myelin. J. Neurochem. 1987, 49:1863-1872.
20. Carenini S., Montag D., Schachner M., Martini R. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice. Glia 1999, 27:203-212.
21. Cheng L., Mudge A.W. Cultured Schwann cells constitutively express the myelin protein P0. Neuron 1996, 16:309-319.
22. Combet C., Blanchet C., Geourjon C., Deleage G. NPS@: Network protein sequence analysis. Trends Biochem. Sci. 2000, 25:147-150.
23. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucl. Acids Res. 1988, 16:10881-10890.
24. Cosgaya J.M., Chan J.R., Shooter E.M. The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 2002, 298:1245-1248.
25. DeJonghe P., Timmerman V., Ceuterick C., Nelis E., DeVriendt E., Lofgren A., Vercruyssen A., Verellen C., VanMaldergem L., Martin J-J., VanBroeckhoven C. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain. 1999, 122:281-290.
26. Ding Y., Brunden K.R. The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J. Biol. Chem. 1994, 269:10764-10770.
27. Doyle J.P., Stempak J.G., Cowin P., Colman D.R., D'Urso D. Protein zero, a nervous system adhesion molecule, triggers epithelial reversion in host carcinoma cells. J. Cell Biol. 1995, 131:465-482.
28. D'Urso D., Brophy P.J., Staugaitus S.M., Gillespie C.S., Frey A.B., Stempack J.G., Colman D.R. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 1990, 2:449-460.
29. Eichberg J. Myelin P0: New knowledge and new roles. Nerochem. Res. 2002, 27:1331-1340.
30. Eichberg J., Iyer S. Phosphorylation of myelin protein: Recent advances. Neurochem. Res. 1996, 21:527-535.
31. Everly J.L., Brady R.O., Quarles R.H. Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein. J. Neurochem. 1973, 21:329-334.
32. Fabrizi G.M., Ferrarini M., Cavallaro T., Jarre L., Polo A., Rizzuto N. A somatic and germline mosaic mutation in MPZ/P0 mimics recessive inheritance of CMT1B. Neurol. 2001, 57:101-105.
33. Fabrizi G.M., Taioli F., Cavallaro T., Rigatelli F, Simonati A., Mariani G., Perrone P., Rizzuto N. Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero. Acta Neuropathol. 2000, 100:299-304.
34. Feltri M.L., D'Antonio M., Previtali S., Fasolini M., Messing A., Wrabetz L. P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann. N. Y. Acad. Sci. 1999, 883:116-123.
35. Feltri M.L., D'Antonio M., Quattrini A., Numerato R., Arona M., Previtali S., Chiu S.Y., Messing A., Wrabetz L. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. Eur. J. Neurosci. 1999, 11:1577-1586.
36. Feltri M.L., Graus Porta D., Previtali S.C., Nodari A., Migliavacca B., Cassetti A., Littlewood-Evans A., Reichardt L.F., Messing A., Quattrini A., Mueller U., Wrabetz L. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 2002, 156:199-209.
37. Fernandez-Valle C., Fregien N., Wood P.M., Bunge M.B. Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation. Development 1993, 119:867-880.
38. Fernandez-Valle C., Gorman D., Gomez A.M., Bunge M.B. Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination. J. Neurosci. 1997, 17:241-250.
39. Filbin M.T., Tennekoon G.I. The role of complex carbohydrates in adhesion of the myelin protein, P0. Neuron 1991, 7:845-855.
40. Filbin M.T., Tennekoon G.I. Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair. J. Cell Biol. 1993, 122:451-459.
41. Filbin M.T., Walsh F.S., Trapp B.D., Pizzey J.A., Tennekoon G.I. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 1990, 344:871-872.
42. Filbin M.T., Wong M.H., Zhang K., Li W.H. The role of myelin P0 protein. Cell Biology and Pathology of Myelin 1997, 103-114. Plenum Press, Amsterdam, New York. B.H.J. Juurlink, R.M. Devon, J.R. Doucette, A.J. Nazarali, D.J. Schreyer, V.M.K. Verge (Eds.).
43. Franklin R.J., Barnett S.C. Olfactory ensheathing cells and CNS regeneration: The sweet smell of success?. Neuron 2000, 28:15-18.
44. Franks N.P., Lieb W.R. Rapid movement of molecules across membranes: Measurement of the permeability coefficient of water using neutron diffraction. J. Mol. Biol. 1980, 141:43-61.
45. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M., Martini R. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 1999, 19:6058-6067.
46. Gallego R.G., Blanco J.L.J., Thijssen-van Zuylen C.W.E.M., Gotfredsen C.H., Voshol H., Duus J.Ø., Schachner M., Vliegenthart J.F.G. Epitope diversity of N-glycans from bovine peripheral myelin glycoprotein P0 revealed by mass spectrometry and nano probe magic angle spinning 1H NMR spectroscopy. J. Biol. Chem. 2001, 276:30834-30844.
47. Gao Y., Li W., Filbin M.T. Acylation of myelin P0 protein is required for adhesion. J. Neurosci. Res. 2000, 60:704-713.
48. Giese K.P., Martini R., Lemke G., Soriano P., Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992, 71:565-576.
49. Giovannini M., Robanus-Maandag E., Niwa-Kawakita M., van der Valk M., Woodruff J.M., Goutebroze L., Merel P., Berns A., Thomas G. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev. 1999, 13:978-986.
50. Gould R.M., Jessen K.R., Mirsky R., Tennekoon G. The cell of Schwann: An update. Myelin: Biology and Chemistry 1992, 123-171. CRC Press, New York. R.E. Martenson (Ed.).
51. Greenfield S., Brostoff S., Eylar E.H., Morell P. Protein composition of myelin of the peripheral nervous system. J. Neurochem. 1973, 20:1207-1216.
52. Griffith L.S., Schmitz B. L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0. J. Neurosci. Res. 1992, 33:639-648.
53. Gupta S.K., Poduslo J.F., Mezei C. Temporal changes in P0 and MBP gene expression after crush-injury of the adult peripheral nerve. Mol. Brain Res. 1988, 4:133-141.
54. Guttinger M., Sutti F., Panigada M., Porcellini S., Merati B., Mariani M., Teesalu T., Consalez G.G., Grassi F. Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J. Cell Biol. 1998, 141:1061-1071.
55. Hagedorn L., Suter U., Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 1999, 126:3781-3794.
56. Hayasaka K., Himoro M., Wang Y., Takata M., Minoshima S., Shimizu HN., Miura M., Uyemura K., Takada G. Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics 1993, 17:755-758.
57. Hayasaka K., Nanao K., Tahara M., Sato W., Takada G., Miura M., Uyemura K. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem. Biophys. Res Commun. 1991, 180:515-518.
58. Hilmi S., Fournier M., Valeins H., Gandar G.C., Bonnet J. Myelin P0 glycoprotein: Identification of the site phosphorylated in vitro and in vivo by endogenous protein kinases. J. Neurochem. 1995, 64:902-907.
59. Inouye H., Karthigasan J., Kirschner D.A. Membrane structure in isolated and intact myelins. Biophys. J. 1989, 56:129-137.
60. Inouye H., Kirschner D.A. Membrane interactions in nerve myelin: I. Determination of surface charge from effects of pH and ionic strength on period. Biophys. J. 1988, 53:235-246.
61. Inouye H., Kirschner D.A. Folding and function of the myelin proteins from primary sequence data. J. Neurosci. Res. 1991, 28:1-17.
62. Inouye H., Tsuruta H., Sedzik J., Uyemura K., Kirschner D.A. Tetrameric assembly of full sequence P0 myelin glycoprotein by synchrotron x-ray scattering. Biophys. J. 1999, 76:423-437.
63. Iyer S., Bianchi R., Eichberg J. Tyrosine phosphorylation of PNS myelin P0 occurs in the cytoplasmic domain and is maximal during early development. J. Neurochem. 2000, 75:347-354.
64. Iyer S., Rowe-Rendleman C.L., Bianchi R., Eichberg J. Tyrosine phosphorylation of myelin protein P0. J. Neurosci. Res. 1996, 46:531-539.
65. Jaegle M., Mandemakers W., Broos L., Zwart R., Karis A., Visser P., Grosveld F., Meijer D. The POU factor Oct-6 and Schwann cell differentiation. Science 1996, 273:507-510.
66. Jeserich G., Waehneldt T.V. Bony fish myelin: Evidence for common major structural glycoproteins in central and peripheral myelin of trout. J. Neurochem. 1986, 46:525-533.
67. Kirschner D.A., Blaurock A.E. Organization, phylogenetic variations and dynamic transitions of myelin structure. Myelin: Biology and Chemistry 1992, 3-78. CRC Press, Boca Raton, FL. R.E. Martenson (Ed.).
68. Kirschner D.A., Caspar D.L.D., Schoenborn B.P., Nunes A.C. Neutron diffraction of nerve myelin. Brookhaven Symposium in Biology, No. 27 1975, III:68-76. Brookhaven National Laboratory, Boca Raton, FL. B.P. Schoenborn (Ed.).
69. Kirschner D.A., Ganser A.L. Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 1980, 283:207-210.
70. Kirschner D.A., Ganser A.L., Caspar D.L.D. Diffraction studies of molecular organization and interactions in myelin membranes. Myelin 1984, 51-95. Plenum Press, Upton, NY. 2nd ed. P. Morell (Ed.).
71. Kirschner D.A., Hollingshead C.J. Processing for electron microscopy alters membrane structure and packing in myelin. J. Ultrastruc. Res. 1980, 73:211-232.
72. Kirschner D.A., Inouye H., Ganser A.L., Mann V. Myelin membrane structure and composition correlated: A phylogenetic study. J. Neurochem. 1989, 53:1599-1609.
73. Kirschner D.A., Inouye H., Saavedra R.A. Membrane adhesion in peripheral myelin: Good and bad wraps with protein P0. Structure 1996, 4:1239-1244.
74. Kirschner D.A., Szumowski K., Gabreëls-Festen A.A.W.M., Hoogendijk J.E., Bolhuis P.A. Inherited demyelinating peripheral neuropathies: Relating myelin packing abnormalities to P0 molecular defects. J. Neurosci. Res. 1996, 46:502-508.
75. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
76. Kuhn R., Pravtcheva D., Ruddle F., Lemke G. The gene encoding peripheral myelin protein zero is located on mouse chromosome 1. J. Neurosci. 1990, 10:205-209.
77. Lagueny A., Latour P., Vital A., Le Masson G., Rouanet M., Ferrer X., Vital C., Vandenberghe A. Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J. Neurol Neurosurg. Psychiatry 2001, 70:232-235.
78. Landon D.N., Hall S. The myelinated nerve fiber. The Peripheral Nerve 1976, 1-105. Chapman and Hall, New York. D.N. Landon (Ed.).
79. Lanwert C., Jeserich G. Structure, heterologous expression, and adhesive properties of the P(0)-like myelin glycoprotein IP1 of trout CNS. Micros. Res. Tech. 2001, 52:637-644.
80. Lee M., Brennan A., Blanchard A., Zoidl G., Dong Z., Tabernero A., Zoidl C., Dent M.A., Jessen K.R., Mirsky R. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol. Cell Neurosci. 1997, 8:336-350.
81. Lee M-J., Calle E., Brennan A., Ahmed S., Sviderskaya E., Jessen K.R., Mirsky R. In early development of the rat mRNA for the major myelin protein P0 is expressed in nonsensory areas of the embryonic inner ear, notochord, enteric nervous system, and olfactory ensheathing cells. Develop. Dynamics 2001, 222:40-51.
82. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 1985, 40:501-508.
83. Lemke G., Chao M. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Develop. 1988, 102:499-504.
84. Lemke G., Lamar E., Patterson J. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1988, 1:73-83.
85. Libbey J.E., McCright Ingeborg J., Tsunoda I., Wada Y., Fujinami R.S. Perpheral nerve protein, P0, as a otential receptor for Theiler's muroine encephalomyelitis virus. J. Neurovirol. 2001, 7:97-104.
86. Liehr T., Ekici A., Hillenbrand R., Rautenstrauss B. Regional localization of rat myelin protein zero Mpz gene to chromosome 13q24-25 by means of FISH. Mamm. Genome. 1995, 6:824-825.
87. Marrosu M.G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C., Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998, 50:1397-1401.
88. Martini R., Mohajeri M.H., Kasper S., Giese K.P., Schachner M. Mice double deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 1995, 15:4488-4495.
89. Martini R., Zielasek J., Toyka K.V., Giese KP., Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 1995, 11:281-286.
90. Matsuoka H., Cheng K-C., Krug M.S., Yazawa Y., Yoo T-J. Murine model of autoimmune hearing loss induced by myelin protein P0. Ann. Otol. Rhinol. Laryngol. 1999, 108:255-264.
91. Maycox P., Ortuno D., Burrola P., Kuhn R., Bieri P., Arrezo J., Lemke G. A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies. Mol. Cell. Neurosci. 1997, 8:405-416.
92. Melcangi R.C., Magnaghi V., Cavarretta I., Martini L., Piva F. Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 1998, 85:569-578.
93. Menichella D.M., Arroyo E.J., Awatramani R., Xu T., Baron P., Vallat J-M., Balsamo J., Lilien J, Scarlato G., Kamholz J., Scherer S.S., Shy M.E. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells. Mol. Cell Neurosci. 2001, 18:606-618.
94. Messing A., Behringer R.R., Hammang J.P., Palmiter R.D., Brinster R.L., Lemke G. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron 1992, 8:507-520.
95. Messing A., Behringer R.R., Wrabetz L., Hammang J.P., Lemke G., Palmiter R.D., Brinster R.L. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. J. Neurosci. 1994, 14:3533-3539.
96. Mews M., Meyer M. Modulation of Schwann cell phenotype by TGF-beta 1: Inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor. Glia 1993, 8:208-217.
97. Misu K., Yoshihara T., Shikama T., Awaki E., Yamamoto M., Hattori N., Hirayama M., Takegami T., Nakashima K., Sobue G. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in asociation with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J. Neurol. Neurosurg. Psychiatry 2000, 69:806-811.
98. Monuki E.S., Weinmaster G., Kuhn R., Lemke G. SCIP: A glial POU domain gene regulated by cyclic AMP. Neuron 1989, 3:783-793.
99. Morgan L., Jessen K.R., Mirsky R. The effects of cAMP on differentiation of cultured Schwann cells: Progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition. J. Cell Biol. 1991, 112:457-467.
100. Morgan L., Jessen K.R., Mirsky R. Negative regulation of the P0 gene in Schwann cells: Suppression of P0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGF beta 1, TGF beta 2 and TGF beta 3. Development 1994, 120:1399-1409.
101. Nagarajan R., Svaren J., Le N., Araki T., Watson M., Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001, 30:355-368.
102. Nelis E., Haites N., Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum. Mutat. 1999, 13:11-28.
103. Nikitin A.Y., Jin J.J., Papewalis J., Prokopenko S.N., Pozharisski K.M., Winterhager E., Flesken-Nikitin A., Rajewsky M.F. Wild type neu transgene counteracts mutant homologue in malignant transformation of rat Schwann cells. Oncogene 1996, 12:1309-1317.
104. Numakura C., Ln C., Ikegami T., Guldberg P., Hayasaka K. Molecular analysis in Japanese patients with Charcot-Marie-Tooth: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum. Mutat. 2002, 20:392-398.
105. Owens G.C., Boyd C.J. Expressing antisense P0 RNA in Schwann cells perturbs myelination. Development 1991, 112:639-649.
106. Peirano R.I., Goerich D.E., Riethmacher D., Wegner M. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell Biol. 2000, 20:3198-3209.
107. Peters A., Palay S.L., Webster H.deF. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells 1991, 231. Oxford University Press, London. 3rd ed.
108. Pham-Dinh D., Fourbil Y., Blanquet F., Mattei M-G., Roeckel N., Latour P., Chazot G., Vandenberghe A., Dautigny A. The major peripheral myelin protein zero gene: Structuree and localization in the cluster of Fcγ receptor genes on human chromosome 1q21.3-q.23. Hum. Molec. Genet. 1993, 2:2051-2054.
109. Planté-Bordeneuve V., Guiochon-Mantel AS., Lacroix C., Lapresle J., Said G. The Roussy-Lévy family: From the original description to the gene. Ann. Neurol. 1999, 46:770-773.
110. Planté-Bordeneuve V., Parman Y., Guiochon-Mantel A., Alj Y., Deymeer F., Serdaroglu P., Eraksoy M., Said G. The range of chronic demyelinating neuropathy of infancy: A clinico-pathological and genetic study of 15 unrelated cases. J. Neurol. 2001, 248:795-803.
111. Poduslo J.F. Golgi sulfation of the oligosaccharide chain of P0 occurs in the presence of myelin assembly but not in its absence. J. Biol. Chem. 1990, 265:3719-3725.
112. Poduslo J.F., Dyck P.J., Berg C.T. Regulation of myelination: Schwann cell transition from a myelin-maintaining state to a quiescent state after permanent nerve transection. J. Neurochem. 1985, 44:388-400.
113. Previtali S.C., Quattrini A., Fasolini M., Panzeri M.C., Villa A., Filbin M.T., Li W., Chiu S.Y., Messing A., Wrabetz L., Feltri M.L. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J. Cell Biol. 2000, 151:1035-1046.
114. Quarles R.H. Glycoproteins of myelin sheaths. J. Moec. Neurosci. 1997, 7:1-12.
115. Saavedra R.A., Fors L., Aebersold R.H., Arden B., Horvath S., Sanders J., Hood L. The myelin proteins of the shark brain are similar to the myelin proteins of the mammalian peripheral nervous system. J. Mol. Evol. 1989, 29:149-156.
116. Sakamoto Y., Kitamura K., Yoshimura K., Nishijima T., Uyemura K. Complete amino acid sequence of P0 protein in bovine peripheral nerve myelin. J. Biol. Chem. 1987, 262:4208-4214.
117. Sato Y., Kimura M., Yasuda Ch., Nakano Y., Tomita M., Kobata A., Endo T. Evidence for the presence of major peripheral myelin glycoprotein P0 in mammalian spinal cord and a change of its glycosylation state during aging. Glycobiol. 1999, 9:655-660.
118. Sayle R., Milner-White E.J. RasMol: Biomolecular graphics for all. Trends Biochem. Sci. 1995, 20:374.
119. Scherer S.S., Wang D.Y., Kuhn R., Lemke G., Wrabetz L., Kamholz J. Axons regulate Schwann cell expression of the POU transcription factor SCIP. J. Neurosci. 1994, 14:1930-1942.
120. Schneider-Schaulies J., von Brunn A., Schachner M. Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties. J. Neurosci. Res. 1990, 27:286-297.
121. Schweitzer J., Becker T., Becker C.G., Schachner M. Expression of protein zero is increased in lesioned axon pathways in the central nervous system of adult zebrafish. Glia 2003, 41:301-317.
122. Senderek J., Hermanns B., Lehmann U., Bergmann C., Marx G., Kabus C., Timmerman V., Stoltenburg-Didinger G., Schroeder M.J. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: Two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol. 2000, 10:235-248.
123. Senderek J., Ramaekers V.T., Zerres K., Rudnik-Schoeneborn S., Schroeder J.M., Bergmann C. Phenotypic variation of a novel nonsense mutation in the P0 intracellular domain. J. Neurol. Sci. 2001, 192:49-51.
124. Shapiro L., Doyle J.P., Hensley P., Colman D.R., Hendrickson W.A. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435-449.
125. Silander K., Meretoja P., Nelis E., Timmerman V., Van Broeckhoven C., Aula P., Savontaus M-L. A de novo duplication in 17p11.2 and a novel mutation in the P0 gene in two Déjérine-Sottas syndrome patients. Hum. Mutat. 1996, 8:304-310.
126. Sindou P., Vallat J-M., Chapon F., Archelos J-J., Tabaraud F., Anani T., Braund K.G., Maisonobe T., Hauw J-J., Vandenberghe A. Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease. Muscle Nerve 1999, 22:99-104.
127. Spiryda L. Myelin protein zero and membrane adhesion. J. Neurosci. Res. 1998, 54:137-146.
128. Spiryda L.B., Colman D.R. Protein zero, a myelin IgCAM, induces physiologically operative tight junctions in nonadhesive carcinoma cells. J. Neurosci. Res. 1998, 54:282-288.
129. Spiryda L.B., Colman D.R. Suppression of tumorigenicity in an aggressive cervical carcinoma induced by protein zero, a nervous system IgCAM. J. Cell Sci. 1998, 111:3253-3260.
130. Stahl N., Harry J., Popko B. Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Mol. Brain Res. 1990, 8:209-212.
131. Stratmann A., Jeserich G. Molecular cloning and tissue expression of a cDNA encoding IP1 - a P0-like glycoprotein of trout CNS myelin. J. Neurochem. 1995, 64:2427-2436.
132. Suzuki M., Sakamoto Y., Kitamura K., Fukunaga K., Yamamoto H., Miyamoto E., Uyemura K. Phosphorylation of P0 glycoprotein in peripheral nerve myelin. J. Neurochem. 1990, 55:1966-1971.
133. Tang D.S., Yu K.P., Tang X., Zhang H., Pan Q., Dai H., Xia J. In silicon [sic] cloning of human myelin protein zero-like genes by bioinformatics strategy. Amer. J. Hum. Genet. 2000, 67:177. (Suppl.).
134. Thompson A.J., Cronin M.S., Kirschner D.A. Myelin protein zero (P0) exists as dimers and tetramers in native membranes of Xenopus laevis peripheral nerve. J. Neurosci. Res. 2002, 67:766-771.
135. Thompson J.D., Higgins D.G., Gibson T.J. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
136. Topilko P., Meijer D. Transcription factors that control Schwann cell development and myelination. Glial Cell Development: Basic Principles and Clinical Relevance 2001, 223-244. Oxford University Press, New York. K.R. Jessen, W.R. Richardson (Eds.).
137. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
138. Trapp B.D., Hauer P., Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J. Neurosci. 1988, 8:3515-3521.
139. Uyemura K., Kitamure K., Miura M. Structure and molecular biology of P0 protein. Myelin: Biology and Chemistry 1992, 481-508. CRC Press, Oxford. R.E. Martenson (Ed.).
140. Uyemura K., Suzuki M., Sakamoto Y., Tanaka S. Structure of P0 protein: Homology to immunoglobulin superfamily. Biomed. Res. 1987, 8:353-357.
141. Voshol H., van Zuylen C.W.E.M., Orberger G., Vliegenthart J.F.G., Schachner M. Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein P0. J. Biol. Chem. 1996, 271:22957-22960.
142. Waehneldt T.V., Matthieu J-M., Jeserich G. Appearance eof myelin proteins during vertebrate evolution. Neurochem. Int. 1986, 9:463-474.
143. Warner L.E., Shohat M., Shorer Z, Lupski J.R. Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas case. Hum. Mutat. 1997, 10:21-24.
144. Weinstein D.E., Burrola P.G., Lemke G. Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol. Cell. Neurosci. 1995, 6:212-229.
145. Wells C.A., Saavedra R.A., Inouye H., Kirschner D.A. Myelin P0-glycoprotein: Predicted structure and interactions of extracellular domain. J. Neurochem. 1993, 61:1987-1995.
146. Wong M.H., Filbin M.T. The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain. J. Cell Biol. 1994, 126:1089-1097.
147. Wong M.H., Filbin M.T. Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain. J. Cell Biol. 1996, 134:1531-1541.
148. Wood J.G., Dawson R.M.C. A major myelin glycoprotein of sciatic nerve. J. Neurochem. 1973, 21:717-719.
149. Wrabetz L., Feltri M., Quattrini A., Inperiale D., Previtali S., D'Antonio M., Martini R., Yin X., Trapp B., Zhou L., Chiu S.-Y., Messing A. P0 overexpression causes congenital hypomyelination of peripheral nerve. J. Cell Biol. 2000, 148:1021-1033.
150. Xu M-J., Zhao R., Sui X., Xu F., Zhao Z.J. Tyrosine phosphyorylation of myelin P0 and its implication in signal transduction. Biochem. Biophys. Res. Commun. 2000, 267:820-825.
151. Xu W., Shy M., Kamholz J., Elferink L., Xu G., Lilien J., Balsamo J. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J. Cell Biol. 2001, 155:439-446.
152. Yamauchi Y., Abe K., Mantani A., Hitoshi Y., Suzuki M., Osuzu F., Kuratani S., Yamamura K. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev. Biol. 1999, 212:191-203.
153. Yan W.X., Archelos J.J., Hartung H-P., Pollard J.D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 2001, 50:282-292.
154. Yin A., Kidd G., Wrabetz L., Feltri M., Messing A., Trapp B. Schwann cell myelination requires timely and precise targeting of P0 protein. J. Cell Biol. 2000, 148:1009-1020.
155. You K-H., Hsieh C-L., Hayes C., Stahl N., Francke U., Popko B. DNA sequence, genomic organization, and chromosomal localization of the mouse peripheral myelin protein zero gene: Identification of polymorphic alleles. Genomics 1991, 9:751-757.
156. Young P., Grote K., Kuhlenbäumer G., Debus O., Kurlemann H., Halfter H., Funke H., Ringelstein E.B., Stögbauer F. Mutation analysis in Charcot-Marie-Tooth disease type 1: Point mutations in the MPZ gene and GJB1 gene cause comparable phenotypic heterogeneity. J. Neurol. 2001, 248:410-415.
157. Zhang K., Filbin M.T. Formation of a disulfide bond in the immunoglobulin domain of the myelin P0 protein is essential for its adhesion. J. Neurochem. 1994, 63:367-370.
158. Zhang S.M., Marsh R., Ratner N., Brackenbury R. Myelin glycoprotein P0 is expressed at early stages of chicken and rat embryogenesis. J. Neurosci. Res. 1995, 40:241-250.
159. Zhao Z.J., Zhao R. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2. J. Biol. Chem. 1998, 273:29367-29372.
160. Zorick T.S., Syroid D.E., Brown A., Gridley T., Lemke G. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 1999, 126:1397-1406.